"/> Novus Biologicals™ Peptide bloquant d’anticorps Br… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Breast carcinoma amplified sequence 3

Réf. : BL-RE-052867Réf. fabricant : 18288425 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
54828
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77125. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the amino terminus of human BCAS3 .

Points forts

Source

Synthetic

(Accession #: EAW51415) The Breast carcinoma amplified sequence 3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-052867
Réf. fabricant18288425
Gene ID (Entrez)54828
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77125. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneBCAS4/BCAS3 fusion, breast carcinoma amplified sequence 3, breast carcinoma amplified sequence 4/3 fusion protein, breast carcinoma-amplified sequence 3, DKFZp686O1527, FLJ20128, GAOB1, MAAB, metastasis associated antigen of breast cancer, MGC4973, protein Maab1
Symbole de gène(s)BCAS3
Type de produitBreast carcinoma amplified sequence 3
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the amino terminus of human BCAS3
Une question, une configuration particulière ?
Contactez-nous pour un devis.